Coppell Advisory Solutions LLC Oncternal Therapeutics, Inc. Transaction History

Coppell Advisory Solutions LLC

  • $606 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.28 - $0.64 $10 - $24
-38 Reduced 65.52%
20 $11,000
Q3 2023

Nov 14, 2023
BUY
$0.29 - $0.48 $6 - $10
22 Added 61.11%
58 $58,000
Q2 2023

Aug 17, 2023
BUY
$0.28 - $0.79 $10 - $28
36 New
36 $13,000
Q1 2023

May 19, 2023
SELL
$0.63 - $1.3 $36 - $75
-58 Closed
0 $0
Q4 2022

May 19, 2023
BUY
$0.86 - $22.2 $49 - $1,287
58 New
58 $58,000

Others Institutions Holding ONCT

# of Institutions
3
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $69.4M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email